24,49 €
1,93 % vorgestern
L&S, 24. Mai, 22:54 Uhr
ISIN
US1638511089
Symbol
CC
Berichte

Chemours Co. Aktie News

Neutral
Accesswire
6 Tage alt
NEW YORK, NY / ACCESSWIRE / May 20, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/the-chemours-company-lawsuit-submission-form?prid=80692&wire=1 or contact Joseph E. Levi, Esq.
Neutral
Accesswire
6 Tage alt
NEW YORK, NY / ACCESSWIRE / May 20, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/the-chemours-company-lawsuit-submission-form?prid=80683&wire=1 or contact Joseph E. Levi, Esq.
Neutral
Accesswire
7 Tage alt
NEW YORK, NY / ACCESSWIRE / May 19, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/the-chemours-company-lawsuit-submission-form?prid=80663&wire=1 or contact Joseph E. Levi, Esq.
Neutral
Accesswire
7 Tage alt
NEW YORK, NY / ACCESSWIRE / May 19, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/the-chemours-company-lawsuit-submission-form?prid=80662&wire=1 or contact Joseph E. Levi, Esq.
Neutral
Accesswire
7 Tage alt
NEW YORK, NY / ACCESSWIRE / May 19, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/the-chemours-company-lawsuit-submission-form?prid=80657&wire=1 or contact Joseph E. Levi, Esq.
Neutral
Accesswire
7 Tage alt
NEW YORK, NY / ACCESSWIRE / May 19, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/the-chemours-company-lawsuit-submission-form?prid=80656&wire=1 or contact Joseph E. Levi, Esq.
Neutral
Accesswire
7 Tage alt
NEW YORK, NY / ACCESSWIRE / May 19, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/the-chemours-company-lawsuit-submission-form?prid=80622&wire=1 or contact Joseph E. Levi, Esq.
Neutral
Accesswire
7 Tage alt
LOS ANGELES, CA / ACCESSWIRE / May 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Chemours Company ("Chemours" or "the Company") (NYSE:CC) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors w...
Mehr News anzeigen

Kostenlos registrieren

aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.

Die Apple Aktie im Überblick mit Charts, aktuellen Kennzahlen, Nachrichten und Aktienanalysen.
Die besten Dividenden-Aktien in der Dividenden-Topscorer-Liste.
Aktienanalysen der besten Aktien weltweit.
Jetzt Vermögen aufbauen